Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypersensitivity Reaction

  Free Subscription


Articles published in J Invest Dermatol

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    November 2022
  1. FANG X, Li M, He C, Liu Q, et al
    Plasma-Derived Exosomes in Chronic Spontaneous Urticaria Induce the Production of Mediators by Human Mast Cells.
    J Invest Dermatol. 2022;142:2998-3008.
    PubMed     Abstract available


    October 2022
  2. YEO H, Ahn SS, Jung E, Lim Y, et al
    Transcription Factor EGR1 Regulates the Expression of the Clock Gene PER2 under IL-4 Stimulation in Human Keratinocytes.
    J Invest Dermatol. 2022;142:2677-2686.
    PubMed     Abstract available


    September 2022
  3. SILVA-VILCHES C, Bolduan V, Alabdullah M, Steinbrink K, et al
    Topical application of adenosine A2-type receptor agonists prevents contact hypersensitivity reactions in mice by affecting skin dendritic cells.
    J Invest Dermatol. 2022 Sep 26. pii: S0022-202X(22)01908.
    PubMed     Abstract available


  4. WU H, Ke X, Huang W, Shi W, et al
    Multi-Tissue Integrative Analysis Identifies Susceptibility Genes for Atopic Dermatitis.
    J Invest Dermatol. 2022 Sep 22. pii: S0022-202X(22)01940.
    PubMed     Abstract available


  5. KOCH M, Kockmann T, Rodriguez E, Wehkamp U, et al
    Quantitative proteomics identifies reduced NRF2 activity and mitochondrial dysfunction in Atopic Dermatitis.
    J Invest Dermatol. 2022 Sep 12. pii: S0022-202X(22)01904.
    PubMed     Abstract available


  6. AGELOPOULOS K, Renkhold L, Wiegmann H, Dugas M, et al
    Transcriptomic, epigenomic and neuro-anatomic signatures differ in chronic prurigo, atopic dermatitis and brachioradial pruritus.
    J Invest Dermatol. 2022 Sep 5. pii: S0022-202X(22)01895.
    PubMed     Abstract available


    August 2022
  7. KIM JH, Ahn S, Ghosh P, Rhee DK, et al
    Immunization with a Pneumococcal pep27 Mutant Strain Alleviates Atopic Dermatitis by Upregulation of Regulatory T Cell Activity and Epithelial Barrier Function and Suppressing TSLP Expression.
    J Invest Dermatol. 2022 Aug 18. pii: S0022-202X(22)01779.
    PubMed     Abstract available


  8. ALMOUGHRABIE S, Gallo RL
    Interdependence of Sebaceous Lipids and the Microbiome in Atopic Dermatitis.
    J Invest Dermatol. 2022 Aug 16. pii: S0022-202X(22)01679.
    PubMed    


  9. DAI X, Muto J, Shiraishi K, Utsunomiya R, et al
    TSLP Impairs Epidermal Barrier Integrity by Stimulating the Formation of Nuclear IL-33/Phosphorylated STAT3 Complex in Human Keratinocytes.
    J Invest Dermatol. 2022;142:2100-2108.
    PubMed     Abstract available


    July 2022
  10. SHO Y, Sakai T, Sato T, Sonezaki M, et al
    Stratum corneum ceramide profiles provide reliable indicators of remission and potential flares in atopic dermatitis.
    J Invest Dermatol. 2022 Jul 20. pii: S0022-202X(22)01664.
    PubMed     Abstract available


  11. OLYDAM JI, de Wijs LEM, Dik WA, Ropke MA, et al
    EASI p-EASI: predicting disease severity in atopic dermatitis patients treated with tralokinumab.
    J Invest Dermatol. 2022 Jul 14. pii: S0022-202X(22)01649.
    PubMed    


  12. HIKINO K, Tanaka N, Koido M, Tomizuka K, et al
    Genetic architectures underlie onset age of atopic dermatitis.
    J Invest Dermatol. 2022 Jul 13. pii: S0022-202X(22)01662.
    PubMed    


    June 2022
  13. MORIMOTO A, Fukuda K, Ito Y, Tahara U, et al
    Microbiota-Independent Spontaneous Dermatitis Associated With Increased Sebaceous Lipid Production in Tmem79-Deficient Mice.
    J Invest Dermatol. 2022 Jun 22. pii: S0022-202X(22)01588.
    PubMed     Abstract available


  14. XUE S, Zhu R, Chen W, Yang H, et al
    Inhibiting Keratinocyte-derived STAT6 Improved Atopic Dermatitis in Mice.
    J Invest Dermatol. 2022 Jun 8. pii: S0022-202X(22)01530.
    PubMed    


  15. PORTER M, Choshi P, Pedretti S, Chimbetete T, et al
    IFN-gamma ELISpot in Severe Cutaneous Adverse Reactions to First-line Anti-tuberculosis Drugs in an HIV Endemic Setting.
    J Invest Dermatol. 2022 Jun 1. pii: S0022-202X(22)01500.
    PubMed     Abstract available


    May 2022
  16. LE TK, Brown I, Goldberg R, Taylor MT, et al
    Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: an Observational, Pharmacovigilance Study.
    J Invest Dermatol. 2022 May 18. pii: S0022-202X(22)00389.
    PubMed     Abstract available


  17. CHEN Y, Chen W
    Genome-wide integration of genetic and genomic studies of atopic dermatitis: Insights into genetic architecture and pathogenesis.
    J Invest Dermatol. 2022 May 13. pii: S0022-202X(22)00390.
    PubMed     Abstract available


    April 2022
  18. WANG J, Pajulas A, Fu Y, Adom D, et al
    gammadelta T cell-mediated Wound Healing is Diminished by Allergic Skin Inflammation.
    J Invest Dermatol. 2022 Apr 1. pii: S0022-202X(22)00255.
    PubMed     Abstract available


  19. BROWN SJ
    Atopic Eczema: How Genetic Studies Can Contribute to the Understanding of this Complex Trait.
    J Invest Dermatol. 2022;142:1015-1019.
    PubMed     Abstract available


    March 2022
  20. LEMAN G, Pavel P, Hermann M, Crumrine D, et al
    Mitochondrial activity is up-regulated in nonlesional atopic dermatitis and amenable to therapeutic intervention.
    J Invest Dermatol. 2022 Mar 24. pii: S0022-202X(22)00205.
    PubMed     Abstract available


  21. WOODS K, Cait A, Gell K, Naidoo K, et al
    Goat milk-derived lipids restrain NKT cell-dependent eosinophilic inflammation in a murine model of atopic dermatitis.
    J Invest Dermatol. 2022 Mar 14. pii: S0022-202X(22)00200.
    PubMed    


  22. SUTARIA N, Alphonse MP, Roh YS, Choi J, et al
    Cutaneous transcriptomics identifies fibroproliferative and neurovascular gene dysregulation in prurigo nodularis compared to psoriasis and atopic dermatitis.
    J Invest Dermatol. 2022 Mar 4. pii: S0022-202X(22)00175.
    PubMed    


  23. GONZALEZ-PEREZ R, Poza-Guedes P, Pineda F, Castillo M, et al
    Atopic Dermatitis and Frequency of Der p 11 Binding as a Major Allergen Revisited.
    J Invest Dermatol. 2022;142.
    PubMed    


  24. GATTINGER P, Huang HJ, Valenta R, Vrtala S, et al
    Response to Gonzalez-Perez et al.
    J Invest Dermatol. 2022;142.
    PubMed    


  25. MIZUKAWA Y, Aoyama Y, Takahashi H, Takahashi R, et al
    Risk of Progression to Autoimmune Disease in Severe Drug Eruption: Risk Factors and the Factor-Guided Stratification.
    J Invest Dermatol. 2022;142.
    PubMed     Abstract available


    February 2022
  26. PADHI A, Srivastava A, Ramesh A, Ehrstrom M, et al
    IL-22 Downregulates Peptidylarginine Deiminase-1 in Human Keratinocytes: Adding Another Piece to the IL-22 Puzzle in Epidermal Barrier Formation.
    J Invest Dermatol. 2022;142:333-342.
    PubMed     Abstract available


    January 2022
  27. MISHRA SK
    The Role of CNTNAP2 in Itch Sensation.
    J Invest Dermatol. 2022;142:251-253.
    PubMed    


  28. DAI X, Shiraishi K, Muto J, Utsunomiya R, et al
    Nuclear IL-33 Plays an Important Role in IL-31Mediated Downregulation of FLG, Keratin 1, and Keratin 10 by Regulating Signal Transducer and Activator of Transcription 3 Activation in Human Keratinocytes.
    J Invest Dermatol. 2022;142:136-144.
    PubMed     Abstract available


    November 2021
  29. ZHANG Z, Elder JT
    Making Lemonade: Putting the Wisdom of the Genome to Work in Atopic Dermatitis.
    J Invest Dermatol. 2021;141:2561-2564.
    PubMed     Abstract available


  30. MIZAWA M, Matsumura K, Hamazaki K, Furukawa F, et al
    Infantile Hemangioma and the Risk Factors in a Japanese Population: A Nationwide Longitudinal Study-The Japan Environment and Children's Study.
    J Invest Dermatol. 2021;141:2745-2748.
    PubMed    


  31. DAI X, Utsunomiya R, Shiraishi K, Mori H, et al
    Nuclear IL-33 Plays an Important Role in the Suppression of FLG, LOR, Keratin 1, and Keratin 10 by IL-4 and IL-13 in Human Keratinocytes.
    J Invest Dermatol. 2021;141:2646-2655.
    PubMed     Abstract available


  32. SHIDO K, Kojima K, Shirota M, Yamasaki K, et al
    GWAS Identified IL4R and the Major Histocompatibility Complex Region as the Associated Loci of Total Serum IgE Levels in 9,260 Japanese Individuals.
    J Invest Dermatol. 2021;141:2749-2752.
    PubMed    


    October 2021
  33. KLOPOT A, Baida G, Kel A, Tsoi LC, et al
    Transcriptome analysis reveals intrinsic pro-inflammatory signaling in healthy African American skin.
    J Invest Dermatol. 2021 Oct 29. pii: S0022-202X(21)02400.
    PubMed     Abstract available


  34. CASTILLO R, Subudhi I, Naik S
    Fanning the Flames: IRAK2 Signaling in Differentiated Epithelium Potentiates Skin Inflammation.
    J Invest Dermatol. 2021;141:2325-2327.
    PubMed     Abstract available


  35. SHAO S, Tsoi LC, Swindell WR, Chen J, et al
    IRAK2 Has a Critical Role in Promoting Feed-Forward Amplification of Epidermal Inflammatory Responses.
    J Invest Dermatol. 2021;141:2436-2448.
    PubMed     Abstract available


    September 2021
  36. HAILFINGER S, Schulze-Osthoff K
    Impaired Autophagy in Psoriasis and Atopic Dermatitis: A New Therapeutic Target?
    J Invest Dermatol. 2021 Sep 23. pii: S0022-202X(21)01409.
    PubMed     Abstract available


    July 2021
  37. TANAKA R, Ichimura Y, Kubota N, Saito A, et al
    Differential involvement of programmed cell death ligands in skin immune responses.
    J Invest Dermatol. 2021 Jul 23. pii: S0022-202X(21)01458.
    PubMed     Abstract available


  38. ZHU Y, Mitra N, Feng Y, Tishkoff S, et al
    FLG Variation Differs between European Americans and African Americans.
    J Invest Dermatol. 2021;141:1855-1857.
    PubMed    


  39. LYUBCHENKO T, Collins HK, Vang KA, Leung DYM, et al
    SMOC1 and IL-4 and IL-13 Cytokines Interfere with Ca(2+) Mobilization in Primary Human Keratinocytes.
    J Invest Dermatol. 2021;141:1792-1801.
    PubMed     Abstract available


    June 2021
  40. VAN DEN BOGAARD EH, Perdew GH
    The Enigma of AHR Activation in the Skin: Interplay among Ligands, Metabolism, and Bioavailability.
    J Invest Dermatol. 2021;141:1385-1388.
    PubMed     Abstract available


  41. DE GROOT R, Bosma AL, Cornet R, Spuls PI, et al
    The Selection Process for a Web-Based Application to Measure Patient-Reported Outcomes Following the Example of the TREAT NL Registry.
    J Invest Dermatol. 2021;141:1592-1595.
    PubMed    


    May 2021
  42. NOE MH
    Understanding Epidermal Necrolysis after the Initial Hospitalization.
    J Invest Dermatol. 2021;141:1139-1140.
    PubMed     Abstract available


  43. WANG Z, Yoo YJ, De La Torre R, Topham C, et al
    Inverse Correlation of TRIM32 and Protein Kinase C zeta in T Helper Type 2-Biased Inflammation.
    J Invest Dermatol. 2021;141:1297-1307.
    PubMed     Abstract available


    April 2021
  44. BRAUWEILER AM, Leung DYM, Goleva E
    The Transcription Factor p63 Is a Direct Effector of IL-4- and IL-13-Mediated Repression of Keratinocyte Differentiation.
    J Invest Dermatol. 2021;141:770-778.
    PubMed     Abstract available


  45. PENG W, Kwiek B, Yu C, Garbi N, et al
    Infiltration and Clustering of Major Histocompatibility Complex II(+) Antigen-Presenting Cells in the Skin of Patients with Atopic Dermatitis.
    J Invest Dermatol. 2021;141:939-942.
    PubMed    


    March 2021
  46. NOVACKOVA A, Sagrafena I, Pullmannova P, Paraskevopoulos G, et al
    Acidic pH is Required for the Multilamellar Assembly of Skin Barrier Lipids in Vitro.
    J Invest Dermatol. 2021 Mar 3. pii: S0022-202X(21)00238.
    PubMed     Abstract available


  47. THOMAS J, Wang R, Batra R, Bohner A, et al
    CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis.
    J Invest Dermatol. 2021;141:681-685.
    PubMed    


  48. HART PH, Norval M
    The Multiple Roles of Urocanic Acid in Health and Disease.
    J Invest Dermatol. 2021;141:496-502.
    PubMed     Abstract available


  49. SHTESSEL M, Limjunyawong N, Oliver ET, Chichester K, et al
    MRGPRX2 Activation Causes Increased Skin Reactivity in Patients with Chronic Spontaneous Urticaria.
    J Invest Dermatol. 2021;141:678-681.
    PubMed    


    February 2021
  50. ABERER E, Sperr WR, Bretterklieber A, Avian A, et al
    Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis (ECNM).
    J Invest Dermatol. 2021 Feb 10. pii: S0022-202X(21)00102.
    PubMed     Abstract available


  51. YEO H, Ahn SS, Lee JY, Jung E, et al
    Disrupting the DNA binding of EGR-1 with a small-molecule inhibitor ameliorates 2,4-dinitrochlorobenzene-induced skin inflammation.
    J Invest Dermatol. 2021 Feb 3. pii: S0022-202X(21)00082.
    PubMed    


  52. BERNA R, Mitra N, Lou C, Wan J, et al
    TSLP and IL-7R Variants Are Associated with Persistent Atopic Dermatitis.
    J Invest Dermatol. 2021;141:446-450.
    PubMed    


  53. MIRANDA E, Roberts J, Novick S, Lapointe JM, et al
    Immunohistochemical Characterization of the IL-13:IL-4 Receptor alpha Axis in the Skin of Adult Patients with Moderate to Severe Atopic Dermatitis and Healthy Controls.
    J Invest Dermatol. 2021;141:440-443.
    PubMed    


    December 2020
  54. CHU MT, Wang CW, Chang WC, Chen CB, et al
    Granulysin-based lymphocyte activation test for evaluating drug causality in antiepileptics-induced severe cutaneous adverse reactions.
    J Invest Dermatol. 2020 Dec 16. pii: S0022-202X(20)32398.
    PubMed     Abstract available


    November 2020
  55. MARXER CA, Frey N, Bodmer M, Bircher A, et al
    Survival after Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis: A UK-based Cohort Study.
    J Invest Dermatol. 2020 Nov 19. pii: S0022-202X(20)32292.
    PubMed     Abstract available


  56. BOJANOWSKI K, Swindell WR, Cantor S, Chaudhuri RK, et al
    Isosorbide di-(linoleate/oleate) stimulates pro-differentiation gene expression to restore the epidermal barrier and improve skin hydration.
    J Invest Dermatol. 2020 Nov 9. pii: S0022-202X(20)32282.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: